Post-earnings recap
Reported
Tue, Aug 6, 2024
EPS actual
$-1.10
EPS est.
$-0.99
EPS surprise
-10.78%
1-day move
+1.64%
Vaxcyte Inc reported a larger-than-expected loss per share, which typically raises concerns among investors. However, the stock rose by 1.64%, suggesting that investors may be optimistic about the company's future prospects despite the EPS miss. The lack of revenue data and guidance leaves some uncertainty, but management's positive outlook on their pipeline could be a driving factor for the stock's performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.10 | N/A | -10.78% |
| Revenue | N/A | N/A | N/A |
Management remains focused on advancing their product candidates. They acknowledged the challenges but emphasized their commitment to long-term goals.
Management highlighted ongoing developments in their pipeline.
They expressed confidence in future growth despite the current EPS miss.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—